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AbstRAct
Objectives: Assessment of fetal growth has an important effect on perinatal morbidity and mortality. To understand what 
tool to choose best for a given population a basic knowledge of how growth charts are developed and used has to be 
acquired. For this reason, this literature review was performed. 
Material and methods: An extensive literature review aimed at identifying articles related to the development of growth 
assessment in both spectrums of abnormal fetal growth — large and small. The analyzed articles were chosen and presented 
to show both the historical aspects of growth assessment, current trends and future considerations. 
Results: Identification of both large and small fetuses and neonates is equally crucial. Definitions and methodology vary 
worldwide and there is an ongoing discussion on the best tool to choose for a given population. An important part of the 
debate is how to differentiate between the physiologically small fetus and the truly growth restricted fetus who is at risk 
of perinatal complication. Similarly, the diagnosis of a large fetus is important in prevention of perinatal complications and 
surgical deliveries. Many clinical settings still lack growth standards.
conclusions: Birthweight for gestational age charts are biased for weight in preterm birth. Prediction and management 
of outcome cannot be based solely on fetal size. Small is not the only problem, we have to think large as well. A common 
misunderstanding in clinical practice is not using uniform charts in defining growth. 
Key words: growth charts; small for gestational age; large for gestational age; appropriate for gestational age; growth 
standard; growth reference
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IntROductIOn
Growth assessment is crucial for predicting fetal wellbe-
ing. It cannot be properly defined without a tool that best fits 
a studied population. Numerous growth charts have been 
developed. Only a handful of countries have recommenda-
tions for detection and management of abnormal growth, 
but still many do not have such standards [1]. Views around 
the world vary, for growth charts can be based on data col-
lected locally or internationally. Some believe that in optimal 
conditions growth is the same irrelevant of ethnicity, others 
believe that local standards work better. A third group be-
lieves that growth should be customized based on maternal 
characteristics, including ethnicity, parity, maternal height 
and weight [2]. To understand what tool to choose best for 
a given population a basic knowledge of how growth charts 
are developed and used has to be acquired. For this reason, 
we have performed this literature review. 
A historical perspective
Historically a strong association between fetal size 
and perinatal mortality has always been recognized. In 
1950 World Health Organization has established a definition 
of Low Birth Weight (LBW) in which infants weighing less 
than 2500 grams at birth were considered “premature” [3]. 
Unfortunately, such definition has failed to differentiate 
between those born too small because born too soon from 
those born small because of growth restriction. Lubchenco 
et al. developed the first weight-for-gestational age per-
centile chart. Basing on it they introduced a classification 
were infants below the 10th percentile were named SGA 
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— small-for-gestational-age, between 10-90th percentile 
AGA — appropriate for gestational age and above the 90th 
centile LGA — large for gestational age [4]. 
In the late 60’s two groups published cross-classifica-
tions of birthweight and gestational age. Yerushalmy et al. 
suggested that neonatal mortality was linked to birthweight 
and gestational age. In group 1, all weighing < 1500 grams 
had a reported neonatal mortality of 707.3/1000; group 
2 < 37 weeks, weighing 1501–2500 gram 104.7/1000, 
group 3 (> 37 wks, 1501–2500 grams) 32/1000, group 4 
(< 37 wks. and > 2500 grams) 13.7 per thousand and group 
V (> 37 wks and > 2500 grams) 4.7/1000 [5]. A similar very 
complex classification was also developed by Lubchenco, 
which included 9 different risk groups [4]. This has led to the 
false assumption that weighing more than 2500 grams at 
term is enough. This association was predominately limited 
by the obvious inadequacy of pregnancy dating before the 
widespread development and use of early gestation ultra-
sound. The current perinatal mortality in different popula-
tions varies from 4–8/1000. Lowering these rates remains 
a constant challenge of perinatal medicine. 
An important question remains how to define the op-
timal cut off point for SGA and FGR. Although often used 
interchangeably, these are two different entities. Different 
cut-offs have been proposed — the 3rd, 5th, 10th and 15th 
centiles. Predominantly the 10th centile has been used. In 
some countries use of -2 standard deviations dominates [6]. 
Another alternative is a reference based on relative risk, 
where a weight correlation with a 2-fold, 2,5-fold and 3-fold 
risk of neonatal death at each gestational age has been 
established [7]. Another methodology was built on an out-
come-based standard which also incorporates differences 
between singleton and multiple gestations [8]. The latter 
study has also addressed the problem that not only small 
but also excess fetal and neonatal weight is a risk factor for 
abnormal outcome.
Via the development of ultrasound methods and preg-
nancy dating, it was soon established that the earlier growth 
charts were biased especially for preterm deliveries. So, 
a question followed what to base the estimation of size 
on. Many tools were developed over time which will be 
described in the lower sections of this article. Recently more 
attention is given to the other side of the growth spectrum. 
LGA and macrosomia are coming into the research scope. 
The question therefore arises, what it means to achieve 
an optimal growth potential for it seems it is not the same 
as being the right size. 
defining optimal weight 
Optimal growth reflects the quality of intrauterine life 
and is a predictor of neonatal outcome. It is affected by 
many factors: maternal, fetal and placental. Growth charts 
can be standard or reference and can be obtained based on 
newborn weight or prenatal ultrasound estimation of foetal 
weight [9]. Reference growth charts reflect how growth is 
in a given population while standard growth charts reflect 
how growth should be [10]. Therefore the first will include 
records with risk factors affecting growth, while the latter 
will represent growth in optimal conditions without influ-
encing factors [9]. Undeniably to determine pathological 
growth both large and small, a gold-standard tool has to 
be established. The discussion is whether it is better done 
by local reference, global standardization or customization. 
WHO and Intergrowth are international attempts to develop 
such standards [11, 12]. The philosophy behind these pro-
jects is that in fetal life and up to the age of five growth is the 
same regardless of ethnicity, maternal or fetal predisposing 
factors [12]. On the other hand, one of the most commonly 
used newborn growth chart is the Fenton growth chart 
which is a metanalysis of local reference charts from differ-
ent parts of the world [13]. Similarly, the Yudkin, Alexander, 
Lubchenco growth charts used for prenatal growth assess-
ment are indeed reference charts derived from newborn 
birth weights [14]. 
Those birthweight-for-gestational-age charts have sev-
eral limitations. First of all, accurate information on gesta-
tional age is needed for constructing them. In the case of 
early charts, from the beginning it was known that they were 
biased especially for preterm deliveries [4]. The rationale be-
hind it was that preterm birth has a component of abnormal 
placentation which affects growth, therefore neonates born 
preterm are smaller than their peers that have continued 
to grow in utero. This is reflected when comparing with 
charts based on estimated fetal weight. Secondly the first 
birth-for-gestational age charts did not exclude pregnancies 
with pathologies affecting growth. Weiner and colleagues 
compared conventional charts with in utero charts showing 
this relationship and concluding that preterm infants may be 
affected by suboptimal growth [15]. This was later compared 
in studies by Secher and Ott [16, 17]. In conclusion con-
ventional charts classify a smaller proportion of FGR across 
gestational ages. The relationship between spontaneous 
preterm birth and birthweight is crucial to understanding its 
bias on reference charts. Morken and colleagues, examined 
the risk of spontaneous preterm birth among over 1 million 
births and found that both undergrowth and overgrowth are 
associated with early parturition [(95% CI 1.1, 1.2) vs (95% 
CI 1.5, 1.7)] [18].
The INTERGROWTH-21st Project was aimed at designing 
an international growth standard based on a description of 
how individuals in healthy communities grow regardless of 
ethnic origin. 60,000 participants have been enrolled. The 
eligibility criteria were designed to identify healthy popu-
lations, following current health recommendations and 
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living in environments highly unlikely to constrain growth. 
It included 3 complementary components: a cross-sectional 
study of all newborns in eight study sites located in Europe, 
Asia, Africa and the Americas; a cohort of healthy women 
in a longitudinal component to monitor fetal growth with 
ultrasound scans every 5 ± 1 weeks from 9–14 weeks of 
gestation to birth. The cohort was then followed for two 
years to assess health, growth, and neurodevelopment. 
Finally, in the third component, the postnatal growth of 
prematurely born infants was monitored. The study con-
cluded indeed that growth in optimal health conditions is 
the same regardless of country or ethnicity. Similarly, WHO 
has conducted a study of intrauterine growth standard fol-
lowing similar criteria as INTERGROWTH [12]. They followed 
1,387 healthy women with unconstrained nutritional and 
social background. On the contrary, they have concluded 
that fetal growth showed variation between countries that 
to a lesser extent was affected by maternal size, parity and 
fetal sex. In conclusion the authors suggested that these 
charts are more suitable for international use. The observed 
differences should be included in adjustment of the growth 
standard for local clinical use to increase the diagnostic and 
predictive performance [11].
Nicolaides at al. created a birth-weight and estimated fe-
tal weight chart for all babies at a given gestational age [19]. 
The main reason for such aim was, that the regular approach 
of deriving birth-weight charts is misleading, since a large 
proportion of babies born preterm arise from pathological 
pregnancy, while reference ranges of estimated fetal weight 
are representative of the whole population but are also 
subject to a percentage error. Two datasets were created. 
First comprised of 5163 paired measurements of estimated 
fetal weight and birth weight; ultrasound examinations were 
carried out at 22–43weeks’ gestation and birth occurred 
within 2 days of the ultrasound examination. Second com-
prised of 95 579 pregnancies with EFW obtained by routine 
ultrasonographic fetal biometry at certain time of pregnancy 
(20 + 0 to 23 + 6 weeks, 31 + 0 to 33 + 6 weeks or 35 + 0 to 
36 + 6 weeks). The study has demonstrated that a very high 
proportion of preterm births are SGA. Authors have estab-
lished a birthweight chart for all babies at a given gestational 
age, including those still in utero. Birthweight and estimated 
fetal weight charts had a common median but differ in the 
levels of spread from the median [12].
Mikolajczyk et al. created a generic adaptable for lo-
cal populations reference for fetal and birthweight. Using 
Hadlock’s fetal-weight reference and Gardosi’s notion of 
proportionality they created a weight reference for any local 
population adjustable to the mean birthweight at 40 weeks 
gestational age. The method was validated using data from 
Data the 2004–08 WHO Global Survey on Maternal and Peri-
natal Health (237,025 births, 24 countries), They concluded 
that this system can be easily adapted to local populations 
and has a better ability to predict adverse perinatal out-
comes than non-customized fetal-weight reference and is 
simpler to use than the individualized reference without 
loss of predictive ability. They stressed the financial burden 
of developing local charts, promoting their method for low 
income countries [20].
Customization of growth is a method developed by 
Gardosi et al. that uses coefficients for maternal race, parity, 
height, weight, smoking and fetal sex to determine opti-
mal growth [21]. The coefficients are generated based on 
birth-weight-for-gestational age charts for a given popula-
tion. Grow charts are generated separately for each fetus 
to reflect his/her individual growth potential. Customized 
growth standard was developed for UK population at first, 
but the idea of customization is gaining popularity and 
therefore customized growth charts are available for many 
other populations [2]. 
Different growth charts were compared in a retrospec-
tive head-to-head manner for abnormal growth detection 
and adverse outcome prediction. Most presented studies 
reveal that use of customized standard increased detec-
tion rate of SGA babes and therefore could help to predict 
adverse outcome [22–24]. Some authors on the other hand 
did not find any added value in using customized growth 
charts in given population [25].
Effect of customization of growth standard in LGA 
is a much less studied problem. Bukowski et al. made 
a case-control study of stillbirths. Authors found that being 
LGA was a significant risk factor of stillbirth, but this was vis-
ible only when using customized or ultrasound norms [26].
2014 Cochrane systematic review concluded that there 
are no good quality evidence papers to be included into 
review [25]. More recent meta-analysis of observational 
studies by Chiossi et al. concluded that customized growth 
charts performed better than population growth charts in 
identification of at risk SGA but not LGA babies [27]. 
definitions, detection and consequences
The two main aims of assessing growth is to plan obstetri-
cal interventions and to anticipate newborn needs at birth. 
Small for gestational age and large for gestational age are the 
opposite spectrums of abnormal growth. Fetal growth restric-
tion and macrosomia are definitions reflecting pathologically 
abnormal growth that require subsequent monitoring and 
adequate management. Therefore, respectively they are not 
synonyms of SGA and LGA. SGA is a birth weight definition 
representing fetuses and newborns that are smaller than their 
counterparts at the same gestational age whereas LGA re-
flects fetuses that are larger. Macrosomia on the other hand 
by definition is estimated fetal weight, with most commonly 
accepted cutoffs of above 4000 or 4500 g [28].
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The primary aim of detection of large fetuses is preven-
tion of stillbirth, shoulder dystocia, maternal peripartum 
hemorrhage, injuries of both mother and neonate, cesar-
ean section as well risk of maternal diabetes and metabolic 
syndrome in childhood [29]. In recent study Caradoux et al. 
compared different strategies to predict macrosomia and 
LGA. Authors compared longitudinal growth assessment, 
abdominal circumference longitudinal growth assessment 
and third trimester cross-sectional evaluation. Longitudi-
nal assessment used second trimester and third trimester 
growth velocity. Ultrasound scans and pregnancy outcomes 
of 2696 women were analyzed. Authors concluded that 
single assessment of abdominal circumference in third 
trimester performed better than longitudinal growth as-
sessment [30].
If LGA or macrosomia are risk factors of stillbirth remains 
controversial. Study by Bukowski et al. showed that there is 
a significant relation between LGA and stillbirth if individu-
alized growth charts are used. This relation was not visible 
when using population growth charts [26].
The concept of FGR except for smallness reflects also the 
placenta related underlying pathology. ACOG defines FGR as 
a fetus failing to reach its growth potential in absence of any 
pathological conditions or toxic factors. Because of differ-
ent population standards there is no single optimal weight 
related definition for growth restriction. Some authors con-
sider an infant to have FGR if birth weight falls below the 3rd 
percentile or below two standard deviations of the mean for 
a given gestational age [31]. Various definitions of fetal growth 
restriction based on population norms result in discrepancy 
in FGR diagnosis. The same infant maybe diagnosed on one 
growth chart as FGR but may be above the 10th percentile 
cutoff on another growth standard [32, 33]. In effect the re-
ported incidence has a wide range from 4 to 8 % in developed 
countries and up to 30% in developing countries [9]. The 
latest published definition of FGR is a result of implementing 
a Delphi protocol to reach an international consensus. 56 ex-
perts were asked questions about importance of ultrasound 
findings for growth restriction diagnosis. The final definitions 
are presented in Table 1. Although this definition is not a result 
of direct clinical investigation but an expert opinion it is most 
commonly used in research settings and management proto-
cols [34]. The experts had agreed that fetal weight should not 
be based on customized standards. The reported incidence 
of LGA vary between studies from 4,6% to 15,9%, depending 
on study population and growth chart used [33, 35]. 
conclusions and future considerations
It is a well-established fact that assessing only fetal 
weight is not enough to predict outcome. There are several 
online tools that combine use of size and Doppler indices in 
management of SGA and its differentiation from FGR (Fetal 
Medicine Foundation and Fetal Medicina Barcelona Calcu-
lator). There are several ongoing trials for prediction and 
management of pregnancies complicated by overgrowth. 
Management tools such as those for SGA are yet to be es-
tablished. Perhaps in future artificial intelligence will allow 
research to analyze the many combinations of factors that 
affect fetal growth and neonatal outcome (fetal, maternal, 
environmental and placental). 
What is known?
Birthweight for gestational age charts are biased for 
weight in preterm birth. 
A single size assessment does not reflect the growth 
potential. Local population standards perform better 
than global standards. Randomized trials of customization 
are needed for validation of its use in prevention of com-
plications especially in preterm pregnancies. 
What is not known?
Prediction and management of outcome cannot be 
based solely on fetal size; other factors have to be consid-
ered. Up to date not one management tool, recommenda-
tion nor standard has been proven to be superior. 
What is misunderstood?
Small is not the only problem, we have to think large as 
well. A common misunderstanding in clinical practice is not 
using uniform charts in defining growth. Basing decision 
solely on fetal size, without considering other factors such as 
Doppler assessment can result in unnecessary interventions. 
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